Clinical Trial Update: Vaccine Therapy Plus Interleukin-2 in Treating Patients With Stage III or Stage IV Melanoma [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating a vaccine therapy in combination with interleukin-2 for stage III or IV melanoma has completed and results have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Melanoma

Drugs mentioned

• Interleukin-2 (Proleukin) (interleukin-2)

Snippet

Sponsor: University of Virginia | Conditions: Melanoma (Skin) | Phase 2 | Status: COMPLETED | Results posted: 2014-12-19